Dave Sunderhaft Joins REDCap Cloud as EVP, Commercial Operations
Industry leader joins REDCap Cloud to lead the global commercialization of the REDCap Cloud Platform and suite of e-Clinical applications
ENCINITAS, Calif., March 15, 2017 – nPhase, Inc., developer of the most widely used EDC platform for academic, commercial and non-profit organizations, REDCap Cloud EDC, announced today that Dave Sunderhaft, a seasoned industry expert with over 20 years of experience with e-Clinical solutions, has joined REDCap Cloud as the Executive Vice President of Commercial Operations. Prior to joining REDCap Cloud, Mr. Sunderhaft led the eClinical Solutions practice at PAREXEL International, where he was responsible for helping Pharmaceutical, Biotech, CRO and Medical Device companies simplify and automate their clinical research processes using internet based collaboration software. Mr. Sunderhaft will report directly to the CEO of the company.
‘We are pleased to be able to have someone of Dave’s experience and knowledge join our organization”, noted Scott Climes, CEO of nPhase. “As we continue to pursue our commitment of advancing innovation and closing the gap between academic, non-profit funded research, and the commercial world, having someone of Dave’s caliber lead our product development, commercialization, and delivery organizations will be instrumental to achieving our goals.”
REDCap Cloud is designed to transform clinical research for the life science industry by offering a cost-effective eClinical platform that enables Sponsors, CROs, investigators, and research teams to collaborate around the world, and to transform patient care in a faster, better, and more cost-effective manner.
About REDCap Cloud
REDCap has been developed by Vanderbilt University for over a decade and is widely used by academic research centers, major nonprofit organizations, and government agencies around the world to support clinical and translational research. The REDCap Consortium is composed of more than 625,000 users in more than 115 countries and has been used in nearly 500,000 research studies. In early 2016, an enhanced commercial-grade version of REDCap, called REDCap Cloud, was launched to support multicenter studies and regulated clinical studies. REDCap Cloud is the first solution to bridge the requirements of both the academic/NPO researchers and the commercial sponsors with technology, functionality, and a business model for all markets. REDCap Cloud is committed to advancing innovation and closing the gap between academic, non-profit funded research, and the commercial world.
For more information, please visit www.redcapcloud.com